VRNA β€” VERONA PHARMA PLC

Ownership history in Capital Analysts, LLC  Β·  3 quarters on record

This page tracks every 13F SEC filing in which Capital Analysts, LLC reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 318 β€” 0% 0.00% $34K β€”
2025 Q2 UNCHANGED 318 β€” 0% 0.00% $30K β€”
2025 Q1 INITIATED 318 β€” β€” 0.00% $20K β€”

🏒 Other funds also holding VRNA

As of 2025 Q3 β€” sorted by position size

SYQUANT CAPITAL SAS 3Y 37.01% Twin Securities, Inc. 3Y 7Y 26.58% Vazirani Asset Management LLC 3Y 22.88% Aisling Capital Management LP 3Y 7Y 14.39% NEA Management Company, LLC 3Y 7Y 13.19% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 12.73% Chicago Capital Management, LLC 3Y 7Y 12.37% Vivo Capital, LLC 3Y 7Y 11.97% KRYGER CAPITAL Ltd 3Y 11.86% GLAZER CAPITAL, LLC 3Y 7Y 11.48%
← Back to Capital Analysts, LLC Holdings